Financials
- Market Capitalization 26.11 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
14.44
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 474 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 63.00 USD | -0.17% | +2.54% | +10.20% | +69.08% | 28.13 B USD | ||
| 483 | INSM Insmed Incorporated - Common Stock | 126.48 USD | -0.12% | +2.79% | +27.37% | -21.95% | 27.62 B USD | ||
| 510 | BNTX BioNTech SE - American Depositary Shares | 103.81 USD | +1.82% | -6.52% | +16.41% | +3.29% | 24.91 B USD | ||
| 514 | ROIV Roivant Sciences Ltd. - Common Shares | 33.79 USD | -1.14% | -7.98% | +0.18% | +84.54% | 24.41 B USD |